Annual ROA
-699.19%
-375.91%-116.28%
December 31, 2023
Summary
- As of February 8, 2025, SEEL annual return on assets is -699.19%, with the most recent change of -375.91% (-116.28%) on December 31, 2023.
- During the last 3 years, SEEL annual ROA has fallen by -590.00% (-540.34%).
- SEEL annual ROA is now -14696.87% below its all-time high of 4.79%, reached on December 31, 2017.
Performance
SEEL ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
92.82%
+492.50%+123.22%
June 30, 2024
Summary
- As of February 8, 2025, SEEL quarterly return on assets is 92.82%, with the most recent change of +492.50% (+123.22%) on June 30, 2024.
- Over the past year, SEEL quarterly ROA has increased by +409.66% (+129.30%).
- SEEL quarterly ROA is now at all-time high.
Performance
SEEL Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
SEEL ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -116.3% | +129.3% |
| 3 y3 years | -540.3% | +158.9% |
| 5 y5 years | -184.4% | +116.3% |
SEEL ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -783.9% | at low | at high | +123.2% |
| 5 y | 5-year | -783.9% | at low | at high | +122.6% |
| alltime | all time | <-9999.0% | at low | at high | +114.6% |
Seelos Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | 92.82%(-123.2%) |
| Mar 2024 | - | -399.68%(+24.4%) |
| Dec 2023 | -699.19%(+116.3%) | -321.27%(+1.4%) |
| Sep 2023 | - | -316.84%(-3.6%) |
| Jun 2023 | - | -328.75%(+57.2%) |
| Mar 2023 | - | -209.12%(+32.7%) |
| Dec 2022 | -323.28%(+308.7%) | -157.62%(+18.7%) |
| Sep 2022 | - | -132.82%(+30.3%) |
| Jun 2022 | - | -101.94%(+36.1%) |
| Mar 2022 | - | -74.89%(-16.1%) |
| Dec 2021 | -79.10%(-27.6%) | -89.22%(+13.5%) |
| Sep 2021 | - | -78.64%(-18.8%) |
| Jun 2021 | - | -96.86%(-44.5%) |
| Mar 2021 | - | -174.56%(+12.6%) |
| Dec 2020 | -109.19%(-76.4%) | -154.97%(-28.7%) |
| Sep 2020 | - | -217.32%(+19.2%) |
| Jun 2020 | - | -182.31%(+14.7%) |
| Mar 2020 | - | -159.01%(-61.3%) |
| Dec 2019 | -461.92%(+87.9%) | -410.61%(-8.1%) |
| Sep 2019 | - | -446.85%(-21.5%) |
| Jun 2019 | - | -569.18%(-10.4%) |
| Mar 2019 | - | -635.14%(+183.7%) |
| Dec 2018 | -245.80%(-5231.5%) | -223.91%(+76.5%) |
| Sep 2018 | - | -126.86%(-15.7%) |
| Jun 2018 | - | -150.51%(+14.0%) |
| Mar 2018 | - | -132.04%(-3156.5%) |
| Dec 2017 | 4.79%(-103.0%) | 4.32%(-87.9%) |
| Sep 2017 | - | 35.65%(-51.5%) |
| Jun 2017 | - | 73.45%(+43.8%) |
| Mar 2017 | - | 51.08%(-151.0%) |
| Dec 2016 | -158.15%(-6.1%) | -100.08%(-13.3%) |
| Sep 2016 | - | -115.48%(-25.7%) |
| Jun 2016 | - | -155.50%(+0.8%) |
| Mar 2016 | - | -154.23%(+2.5%) |
| Dec 2015 | -168.42%(+47.3%) | -150.46%(-33.4%) |
| Sep 2015 | - | -225.83%(+21.0%) |
| Jun 2015 | - | -186.56%(+48.9%) |
| Mar 2015 | - | -125.28%(+18.7%) |
| Dec 2014 | -114.31%(+59.2%) | -105.56%(+300.0%) |
| Sep 2014 | - | -26.39%(+8.8%) |
| Jun 2014 | - | -24.25%(-52.0%) |
| Mar 2014 | - | -50.49%(-32.6%) |
| Dec 2013 | -71.79%(-54.2%) | -74.92%(-44.5%) |
| Sep 2013 | - | -135.00%(+6.8%) |
| Jun 2013 | - | -126.44%(+0.7%) |
| Mar 2013 | - | -125.52%(+12.5%) |
| Dec 2012 | -156.91%(+53.6%) | -111.62%(+75.7%) |
| Sep 2012 | - | -63.53%(-18.8%) |
| Jun 2012 | - | -78.26%(-22.5%) |
| Mar 2012 | - | -100.98%(-7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -102.13%(-31.1%) | -108.96%(-28.3%) |
| Sep 2011 | - | -152.07%(+10.3%) |
| Jun 2011 | - | -137.83%(+24.4%) |
| Mar 2011 | - | -110.80%(-18.7%) |
| Dec 2010 | -148.29%(-31.8%) | -136.36%(-43.4%) |
| Sep 2010 | - | -240.83%(-11.4%) |
| Jun 2010 | - | -271.94%(-13.0%) |
| Mar 2010 | - | -312.54%(+4.2%) |
| Dec 2009 | -217.31%(+304.1%) | -300.02%(+2993.0%) |
| Sep 2009 | - | -9.70%(-67.2%) |
| Jun 2009 | - | -29.57%(-4.2%) |
| Mar 2009 | - | -30.88%(-43.3%) |
| Dec 2008 | -53.78%(-6.3%) | -54.42%(-39.4%) |
| Sep 2008 | - | -89.80%(+22.7%) |
| Jun 2008 | - | -73.16%(+9.1%) |
| Mar 2008 | - | -67.06%(+11.5%) |
| Dec 2007 | -57.42%(+18.7%) | -60.14%(+12.1%) |
| Sep 2007 | - | -53.65%(+7.3%) |
| Jun 2007 | - | -49.98%(+19.7%) |
| Mar 2007 | - | -41.76%(-15.8%) |
| Dec 2006 | -48.36%(-47.4%) | -49.61%(-15.1%) |
| Sep 2006 | - | -58.44%(-10.3%) |
| Jun 2006 | - | -65.18%(-25.1%) |
| Mar 2006 | - | -87.07%(-8.0%) |
| Dec 2005 | -91.91%(+17.2%) | -94.66%(-1.1%) |
| Sep 2005 | - | -95.73%(-2.3%) |
| Jun 2005 | - | -98.02%(+6.2%) |
| Mar 2005 | - | -92.34%(+12.2%) |
| Dec 2004 | -78.44%(-15.2%) | -82.28%(-12.2%) |
| Sep 2004 | - | -93.67%(+4.2%) |
| Jun 2004 | - | -89.88%(-10.4%) |
| Mar 2004 | - | -100.32%(-2.8%) |
| Dec 2003 | -92.47%(-30.7%) | -103.23%(-13.7%) |
| Sep 2003 | - | -119.68%(-11.3%) |
| Jun 2003 | - | -134.87%(-3.6%) |
| Mar 2003 | - | -139.94%(+7.5%) |
| Dec 2002 | -133.36%(+177.5%) | -130.20%(+27.5%) |
| Sep 2002 | - | -102.13%(+30.3%) |
| Jun 2002 | - | -78.41%(+28.8%) |
| Mar 2002 | - | -60.90%(+28.8%) |
| Dec 2001 | -48.06%(+29.5%) | -47.29%(+29.7%) |
| Sep 2001 | - | -36.46%(+5.5%) |
| Jun 2001 | - | -34.56%(-3.6%) |
| Mar 2001 | - | -35.84%(+14.7%) |
| Dec 2000 | -37.11%(+0.1%) | -31.24%(+37.1%) |
| Sep 2000 | - | -22.79%(-4.4%) |
| Jun 2000 | - | -23.85%(+137.3%) |
| Mar 2000 | - | -10.05% |
| Dec 1999 | -37.07%(-68.0%) | - |
| Dec 1998 | -115.75%(-30.0%) | - |
| Dec 1997 | -165.35% | - |
FAQ
- What is Seelos Therapeutics annual return on assets?
- What is the all time high annual ROA for Seelos Therapeutics?
- What is Seelos Therapeutics annual ROA year-on-year change?
- What is Seelos Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly ROA year-on-year change?
What is Seelos Therapeutics annual return on assets?
The current annual ROA of SEEL is -699.19%
What is the all time high annual ROA for Seelos Therapeutics?
Seelos Therapeutics all-time high annual return on assets is 4.79%
What is Seelos Therapeutics annual ROA year-on-year change?
Over the past year, SEEL annual return on assets has changed by -375.91% (-116.28%)
What is Seelos Therapeutics quarterly return on assets?
The current quarterly ROA of SEEL is 92.82%
What is the all time high quarterly ROA for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly return on assets is 92.82%
What is Seelos Therapeutics quarterly ROA year-on-year change?
Over the past year, SEEL quarterly return on assets has changed by +409.66% (+129.30%)